Insider Transactions in Q1 2025 at Acumen Pharmaceuticals, Inc. (ABOS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2025
|
Daniel Joseph O Connell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,400
+24.89%
|
-
|
|
Jan 06
2025
|
James J. Doherty President and CDO |
BUY
Grant, award, or other acquisition
|
Direct |
62,600
+50.0%
|
-
|
|
Jan 06
2025
|
Amy Schacterle Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,800
+50.0%
|
-
|
|
Jan 06
2025
|
Russell Barton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,800
+26.37%
|
-
|
|
Jan 06
2025
|
Derek M Meisner Chief Legal Officer & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
66,800
+28.87%
|
-
|
|
Jan 06
2025
|
Matt Zuga CFO & Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,800
+20.13%
|
-
|
|
Jan 06
2025
|
Eric Siemers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,800
+27.8%
|
-
|
|
Jan 03
2025
|
Daniel Joseph O Connell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
47,778
-9.51%
|
$47,778
$1.84 P/Share
|
|
Jan 03
2025
|
Russell Barton Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,636
-7.88%
|
$7,636
$1.86 P/Share
|
|
Jan 03
2025
|
Derek M Meisner Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct |
11,122
-10.22%
|
$11,122
$1.84 P/Share
|
|
Jan 03
2025
|
Matt Zuga CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct |
13,235
-6.26%
|
$13,235
$1.84 P/Share
|
|
Jan 03
2025
|
Eric Siemers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,859
-9.24%
|
$10,859
$1.85 P/Share
|